Education
About Us
Working with TipRanks
Follow Us
Lobe Sciences (LOBEF)
OTHER OTC:LOBEF
LOBEF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume171.00
Average Volume (3M)70.62K
Market Cap
$4.95M
Enterprise Value$6.42M
Total Cash (Recent Filing)$24.29K
Total Debt (Recent Filing)C$2.15M
Price to Earnings (P/E)―
Beta-0.69
Next Earnings
Jun 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding192,652,130
10 Day Avg. Volume88,933
30 Day Avg. Volume70,623
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)1.12
Price to Sales (P/S)0.00
P/FCF Ratio-3.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lobe Sciences News
PremiumCompany Announcements
Lobe Sciences Appoints New CFO to Drive Strategic Growth
PremiumCompany Announcements
Lobe Sciences Appoints New CFO to Drive Strategic Growth
PremiumCompany Announcements
Lobe Sciences Secures Funding for Conjugated Psilocin™ Development
PremiumCompany Announcements
Lobe Sciences Restructures Financials with Strategic Transactions
PremiumCompany Announcements
Lobe Sciences Appoints New CEO for Altemia, Inc. to Lead 2025 Product LaunchPremiumCompany Announcements
Lobe Sciences Launches Neurology Subsidiary Alera Pharma
PremiumCompany Announcements
Lobe Sciences Announces Major Leadership Changes
PremiumCompany Announcements
Lobe Sciences Ltd. Board Welcomes New DirectorsOptions Prices
Currently, No data available
---
Ownership Overview
LOBEF FAQ
What was Lobe Sciences’s price range in the past 12 months?
Lobe Sciences lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is Lobe Sciences’s market cap?
Lobe Sciences’s market cap is $4.95M.
When is Lobe Sciences’s upcoming earnings report date?
Lobe Sciences’s upcoming earnings report date is Jun 27, 2025 which is in 13 days.
How were Lobe Sciences’s earnings last quarter?
Lobe Sciences released its earnings results on Apr 28, 2025. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is Lobe Sciences overvalued?
According to Wall Street analysts Lobe Sciences’s price is currently Overvalued.
Does Lobe Sciences pay dividends?
Lobe Sciences does not currently pay dividends.
What is Lobe Sciences’s EPS estimate?
Lobe Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lobe Sciences have?
Lobe Sciences has 192,652,130 shares outstanding.
What happened to Lobe Sciences’s price movement after its last earnings report?
Lobe Sciences reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 50%.
Which hedge fund is a major shareholder of Lobe Sciences?
Currently, no hedge funds are holding shares in LOBEF
Company Description
Lobe Sciences
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
Technical Analysis
Ayurcann Holdings Corp.
―
Willow Biosciences Inc
―
1933 Industries
―
Blueberries Medical
―
4Front Ventures
―